Abstract
The prevalence of sleep disruptions have been reported in 30-50% of cancer patients. Most insomnia cases that involve cancer patients occur in various stages of the disease, with a particular emphasis in the advanced stages. In the literature, insomnia is a specific sleep disruption that is more defined in cancer patients as a symptom or clinical disorder. In oncology patients, insomnia is not only one symptom but a cluster of symptoms that are associated with many risk factors. Better evaluation of the risk factors in cancer patients will be of great assistance for the treatment of sleep disorders in cancer patients. Since there are various diagnostic tests for insomnia, it is important that the diagnosis and follow up is in parallel with these methods. The methods should be proven reliable to validate diagnosis and outcomes for oncology patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
